1-1203755-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_148901.2(TNFRSF18):c.604C>T(p.Arg202Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000237 in 1,560,550 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_148901.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNFRSF18 | NM_004195.3 | c.*89C>T | 3_prime_UTR_variant | 5/5 | ENST00000379268.7 | NP_004186.1 | ||
TNFRSF18 | NM_148901.2 | c.604C>T | p.Arg202Trp | missense_variant | 4/4 | NP_683699.1 | ||
TNFRSF18 | XM_017002722.3 | c.880C>T | p.Arg294Trp | missense_variant | 4/4 | XP_016858211.1 | ||
TNFRSF18 | NM_148902.2 | c.*89C>T | 3_prime_UTR_variant | 5/5 | NP_683700.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152158Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000412 AC: 7AN: 170024Hom.: 0 AF XY: 0.0000646 AC XY: 6AN XY: 92852
GnomAD4 exome AF: 0.0000199 AC: 28AN: 1408274Hom.: 0 Cov.: 32 AF XY: 0.0000287 AC XY: 20AN XY: 697184
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152276Hom.: 0 Cov.: 33 AF XY: 0.0000806 AC XY: 6AN XY: 74462
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2022 | The c.604C>T (p.R202W) alteration is located in exon 4 (coding exon 4) of the TNFRSF18 gene. This alteration results from a C to T substitution at nucleotide position 604, causing the arginine (R) at amino acid position 202 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at